According to Dynavax Technologies 's latest financial reports and stock price the company's current number of shares outstanding is 127,921,000. At the end of 2023 the company had 127,921,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.12 B | 0.26% |
2022 | 0.12 B | 5.12% |
2021 | 0.12 B | 10.17% |
2020 | 0.11 B | 31.37% |
2019 | 83.86 M | 33.77% |
2018 | 62.69 M | 2.77% |
2017 | 61 M | 58.28% |
2016 | 38.54 M | 0.3% |
2015 | 38.42 M | 46.13% |
2014 | 26.29 M | -85.63% |
2013 | 0.18 B | 1.29% |
2012 | 0.18 B | 45.63% |
2011 | 0.12 B | 42.89% |
2010 | 86.82 M | 116.24% |
2009 | 40.15 M | 0.81% |
2008 | 39.83 M | 0.2% |
2007 | 39.75 M | 29.89% |
2006 | 30.6 M | 23.65% |
2005 | 24.75 M | 0.58% |
2004 | 24.6 M | 1264.89% |
2003 | 1.8 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | 5,634,000,000 | 4,304.28% | ๐บ๐ธ USA |
![]() Amgen AMGN | 534,000,000 | 317.45% | ๐บ๐ธ USA |
![]() Biogen BIIB | 144,400,000 | 12.88% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | 1,248,000,000 | 875.60% | ๐บ๐ธ USA |
![]() Merck MRK | 2,536,000,000 | 1,882.47% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | 3,098,000,000 | 2,321.81% | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | 2,022,000,000 | 1,480.66% | ๐ฌ๐ง UK |
![]() Agenus
AGEN | 286,854,000 | 124.24% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | 1,111,000,000 | 768.50% | ๐ฎ๐ฑ Israel |